Abstract
Fungal infection is one of the most common infections affecting millions of people every year. Moreover, it is quiet prevalent in immuno-compromised patients. The recent expansion of antifungal drug research is gaining momentum continuously for the development of new and less toxic antifungals which further gave us an azole group. Nowadays, Azole containing drugs are having immense therapeutic potential with many properties including anti carcinogenic, antibacterial, and antiviral. Current review is mainly focused on the recent trends in efficacy of antifungal property of Azole containing drugs and their further scope and relevance in today’s context.
Keywords: Antifungal therapy, azole compounds, natural products, drugs, antifungals.
The Natural Products Journal
Title:Azoles as Effective Antifungal Agents: Trends, Scope and Relevance
Volume: 4 Issue: 2
Author(s): Vaibhav K. Gupta, Anil K. Sharma, Rohit Sharma, Seema Diwan and Sunil Saini
Affiliation:
Keywords: Antifungal therapy, azole compounds, natural products, drugs, antifungals.
Abstract: Fungal infection is one of the most common infections affecting millions of people every year. Moreover, it is quiet prevalent in immuno-compromised patients. The recent expansion of antifungal drug research is gaining momentum continuously for the development of new and less toxic antifungals which further gave us an azole group. Nowadays, Azole containing drugs are having immense therapeutic potential with many properties including anti carcinogenic, antibacterial, and antiviral. Current review is mainly focused on the recent trends in efficacy of antifungal property of Azole containing drugs and their further scope and relevance in today’s context.
Export Options
About this article
Cite this article as:
Gupta K. Vaibhav, Sharma K. Anil, Sharma Rohit, Diwan Seema and Saini Sunil, Azoles as Effective Antifungal Agents: Trends, Scope and Relevance, The Natural Products Journal 2014; 4 (2) . https://dx.doi.org/10.2174/221031550402141009095854
DOI https://dx.doi.org/10.2174/221031550402141009095854 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Advances in the Synthesis and Development of Curcumin, its Combinations and Formulations and Curcumin-like Compounds as Anti-infective Agents
Current Medicinal Chemistry An Overview on 2-arylquinolin-4(1H)-ones and Related Structures as Tubulin Polymerisation Inhibitors
Current Topics in Medicinal Chemistry Role of α7-Nicotinic Acetylcholine Receptor in Normal and Cancer Stem Cells
Current Drug Targets Trends in Cell-Based Electrochemical Biosensors
Current Medicinal Chemistry Alterations within the Osteo-Hematopoietic Niche in MDS and their Therapeutic Implications
Current Pharmaceutical Design Advances in Fish Cytokine Biology Give Clues to the Evolution of a Complex Network
Current Pharmaceutical Design Insights into the Structural Features Essential for JAK2 Inhibition and Selectivity
Current Medicinal Chemistry MUC Glycoproteins: Potential Biomarkers and Molecular Targets for Cancer Therapy
Current Cancer Drug Targets Dietary Phytochemicals in Chemoprevention of Cancer: An Update
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Targeted Cancer Therapy; Nanotechnology Approaches for Overcoming Drug Resistance
Current Medicinal Chemistry PLK1 Inhibition: Prospective Role for the Treatment of Pediatric Tumors
Current Drug Targets Oncogenic MicroRNAs in the Genesis of Leukemia and Lymphoma
Current Pharmaceutical Design <i>Uncaria tomentosa</i> (Willd. ex Schult.): Focus on Nutraceutical Aspects
Current Bioactive Compounds Histone Methyltransferase Inhibitors: Novel Epigenetic Agents for Cancer Treatment
Current Medicinal Chemistry Stem Cell Genetic Therapy for Fanconi Anemia – A New Hope
Current Gene Therapy A Novel Quinoline Based Second-generation mTOR Inhibitor that Induces Apoptosis and Disrupts PI3K-Akt-mTOR Signaling in Human Leukemia HL-60 Cells
Anti-Cancer Agents in Medicinal Chemistry Modulation of Ornithine Decarboxylase Activity by Phenolics Based Structurally Related Compounds Synthesized on Steroidal and Non-Steroidal Skeleton and their Radical Scavenging Action
Current Bioactive Compounds Chronic Diseases and COVID-19: A Review
Endocrine, Metabolic & Immune Disorders - Drug Targets The Impact of Thrombopoietin on Clinical Practice
Current Pharmaceutical Design Molecular and Cellular Pathways as Treatment Targets for Biologic Therapies in Systemic Sclerosis
Current Medicinal Chemistry